Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Siddiq

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|May 26, 2021
Verna Cheung, Nancy Siddiq, Rebecca Devlin, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|May 26, 2021
Shared-care model for complex chronic haematological malignanciesVerna Cheung, Nancy Siddiq, Rebecca Devlin, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Sabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Sabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Myeloproliferative neoplasms (MPNs) - Part 2: A nursing guide to managing the symptom burden of MPNsSabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Myeloproliferative neoplasms (MPNs) - Part 1: An overview of the diagnosis and treatment of the "classical" MPNsSabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Blood Advances|January 4, 2018
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyJay Y Spiegel, Caroline McNamara, James A Kennedy, et al.
Blood Advances|October 18, 2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomesCaroline J McNamara, Tony Panzarella, James A Kennedy, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|May 26, 2021
Verna Cheung, Nancy Siddiq, Rebecca Devlin, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|May 26, 2021
Shared-care model for complex chronic haematological malignanciesVerna Cheung, Nancy Siddiq, Rebecca Devlin, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Sabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Sabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Myeloproliferative neoplasms (MPNs) - Part 2: A nursing guide to managing the symptom burden of MPNsSabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|June 1, 2019
Myeloproliferative neoplasms (MPNs) - Part 1: An overview of the diagnosis and treatment of the "classical" MPNsSabrina Fowlkes, Cindy Murray, Adrienne Fulford, et al.
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Blood Advances|January 4, 2018
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyJay Y Spiegel, Caroline McNamara, James A Kennedy, et al.
Blood Advances|October 18, 2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomesCaroline J McNamara, Tony Panzarella, James A Kennedy, et al.
Pageof 1